Metis TechBio Co., Ltd. (HKG:7666)

Hong Kong · Delayed Price · Currency is HKD

12.73

-0.27 (-2.08%)

Jul 9, 2026, 4:08 PM HKT

Market Cap	14.67B
Revenue (ttm)	116.85M +18,853.1%
Net Income	-436.04M
EPS	-4.63
Shares Out	1.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,079,498
Open	13.00
Previous Close	13.00
Day's Range	12.47 - 13.25
52-Week Range	11.53 - 29.98
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Metis TechBio

Metis TechBio Co., Ltd. engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States. It develops NanoForge, a suite of synergistic technologies that includes novo lipid library, AI foundational models, METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. The company also develops specialized platforms, such as AiTEM, AiLNP and AiRNA that simulate, predict, and interpret nan... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2020

Country China

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 7666

Full Company Profile

Financial Performance

In 2025, Metis TechBio's revenue was 105.00 million, an increase of 6985.02% compared to the previous year's 1.48 million. Losses were -391.84 million, -21.51% less than in 2024.

Financial numbers in CNY Financial Statements